Big Data Analysis: The value of genetic information analysis is extremely high

With the rapid development of genetic testing and the ever-decreasing cost, there will be a big outbreak of gene information data, and big data analysis of these gene information will provide valuable medical and scientific data. Today, Bina Technologies, a provider of gene information big data analytics services, announced a $ 6.5 million Series B round of financing.

Today, Bina Technologies, a provider of gene information big data analytics services, announced a $ 6.5 million Series B round of financing, with the major investor being Sierra Ventures. Bina has previously received angel investments from Google and Dropbox.

Genetic testing services are beginning to emerge today, and the cost of genetic testing is declining, but genetic testing companies such as 23andMe do not have a good way to do data analysis after getting large amounts of genetic data, making genetic information widely available application. Bina Technologies offers "big data" to analyze various genetic tests. Bina Technologies was founded in 2011 with team members mainly from mathematicians and biologists at Stanford University and the University of California, Berkeley.

Bina Technologies uses big data to integrate various genetic information analyzes and make genetic data better used in clinical medicine. Gene data analysis provided by Bina Technologies At present and the beginning of practical application, in the United States Wisconsin Medical Center, the focus of the newborn in neonatal intensive care unit (NICU) genome-wide sequencing analysis of the etiology and prevalence trends in children .

Genetic research is a big industry with a value of 15 billion U.S. dollars. With the rapid development of genetic testing and the ever-lower cost of genetic testing, gene information data will explode, and the analysis of these gene informations for big data will be very valuable Medical and scientific data, and Bina Technologies is doing that.